Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas System”
1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10716856
Engineered primate cystine/cysteine degrading enzymes as antineogenic agents
granted -
US 10703721
Caffeic acid derivatives and uses thereof
granted -
US 10703805
Molecular imprinting of West Nile antibodies with physiological pH matching
granted -
US 10703698
Compounds which activate estrogen receptors and compositions and methods of using the same
granted -
US 10696710
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
granted -
US 10688203
Methods of performing brachytherapy
granted -
US 10687520
Generation and correction of a humanized mouse model with a deletion of dystrophin exon 44
granted -
US 10682339
Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same
granted -
US 10682388
Targeting of PELP1 in cancer therapy
granted -
US 10683366
Methods and compositions for treatment of atherosclerosis
granted -
US 10669516
Methods and apparatus for conditioning cell populations for cell therapies
granted -
US 10668085
Thermo-kinetic mixing for pharmaceutical applications
granted -
US 10660850
Compositions and methods of making brittle-matrix particles through blister pack freezing
granted -
US 10661095
Photodynamic therapy for use in treating cancer
granted -
US 10653150
Shelf life and color profile of resin compositions with silver nanoparticles
granted -
US 10646574
Formulations of intraarticular pharmaceutical agents and methods for preparing and using the same
granted -
US 10646438
Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
granted -
US 10639277
Multi-functional echogenic immunoliposomes for directed stem cell delivery to atheroma
granted -
US 10633442
Antibodies to connexin 43 (Cx43) hemichannels and methods of use thereof to inhibit Cx43 hemichannel opening
granted -
US 10633363
EPAC1 activators as HIV latency reversal agents (LRA)
granted -
US 10633411
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
granted -
US 10633657
Methods for treatment of polycystic kidney disease
granted -
US 10633445
T-cell receptor (TCR)-binding antibodies and uses thereof
granted -
US 10626087
Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use of the same
granted